This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Regeneron Pharmaceuticals, Inc., Vlst Corporation. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Dan Allison
Introduction
Dan Allison is an accomplished inventor based in Lake Forest Park, WA (US). He holds a total of 2 patents that showcase his expertise in the field of biochemistry and immunology. His work primarily focuses on the development of antikine antibodies that target multiple CC chemokines, which are crucial in various biological processes.
Latest Patents
One of Dan Allison's latest patents involves antikine antibodies that bind to multiple CC chemokines. These antibodies can attach to two, three, four, five, or more CC chemokines, including RANTES/CCL5, MIP-1α/CCL3, MIP-1β/CCL4, and MCP-1/CCL2. The patent also discloses methods for affinity maturation and humanization of these antikine antibodies, as well as the production of hybridoma cell lines that generate antikine antibodies through sequential immunization.
Career Highlights
Throughout his career, Dan Allison has made significant contributions to the field of biotechnology. He has worked with notable companies such as Vlst Corporation and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antibody development.
Collaborations
Dan Allison has collaborated with various professionals in his field, including Carol J Raport. These partnerships have enhanced his research and led to innovative solutions in the development of therapeutic antibodies.
Conclusion
Dan Allison's work in the field of biochemistry and immunology has led to significant advancements in the development of antikine antibodies. His contributions continue to impact the scientific community and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
